文章摘要
马金萍,王林,党群,李永健,李喜元,张承宗,李广平.慢性心力衰竭住院病例药物治疗的回顾性调查[J].中华流行病学杂志,2007,28(1):78-82
慢性心力衰竭住院病例药物治疗的回顾性调查
Retrospective analysis of drug treatment on inpatients with chronic heart failure
收稿日期:2006-04-20  出版日期:2014-09-15
DOI:
中文关键词: 慢性,心力衰竭  住院病例  药物治疗
英文关键词: Chronic heart failure  Inpatients  Drug treatment
基金项目:天津市科委重点基金资助(033111311)
作者单位E-mail
马金萍 天津医科大学第二医院心脏科 300211  
王林 天津医科大学第二医院心脏科 300211 wang.1in@medmail.com.cn 
党群 天津市第一中心医院  
李永健 天津市第一中心医院  
李喜元 天津医科大学第二医院心脏科 300211  
张承宗 天津医科大学第二医院心脏科 300211  
李广平 天津医科大学第二医院心脏科 300211  
摘要点击次数: 2962
全文下载次数: 958
中文摘要:
      目的了解慢性心力衰竭(心衰)住院病例治疗药物在30年来的应用情况。方法采用两中心、回顾性研究。对药物治疗在年代、性别、年龄、心功能和病因等的分布进行分析。结果入选5189例次,男女比为1:1.02(P>0.05)。平均年龄(62.93±13.49)岁。临床诊断依次是冠心病(44.2%)、风湿性心脏病(24.1%)、肺心病(19.0%)、扩张型心肌病(4.8%)等。人院时心功能以纽约心功能分级(NYHA)Ⅲ级、Ⅳ级为主,分别为40.6%和44.5%。治疗药物总体应用比例为硝酸酯类80.0%、利尿剂71.8%、洋地黄制剂68.1%、血管紧张素转换酶抑制剂(ACEI)52.2%和p.受体阻滞剂19.5%,上述药物的应用逐年代增加。肺心病心衰病例的主要治疗药物也是硝酸酯类、利尿剂、洋地黄制剂。男性应用ACEI多于女性,≥60岁患者应用ACEI和血管紧张素受体拮抗剂(ARB)的比例多于<60岁年龄组,B一受体阻滞剂的应用则无性别和年龄差异。结论慢性心衰住院病例的治疗药物以利尿剂、硝酸酯制剂和洋地黄制剂等为主;ACEI和8一受体阻滞剂的应用增加迅速,虽未达到“指南”的要求,但显示了治疗观念的变化。
英文摘要:
      Objective To investigate drug treatment of inpatients with chronic heart failure(CHF)during the past 30 years in some areas and to provide more information on the treatment strategy of CHF.Methods In two centers a retrospective study was conducted. All data were taken from the hospitalizedcases with chronic heart failure. The medication distributions in different decade,gender,age heart functiongrade and etiology were analyzed. Results 5189 cases were enrolled with the ratio of male to female as1:1. 02. The mean age was ( 62. 93士13.49) years old. The general causes of chronic heatt failure were asfollows: coronary heart disease(44.2%),rheumatic heart disease ( 24. 1%),pulmonary heart disease(19.00,6)and cardiomyopathy (4.8%).The admission cardiac function was mostly seen as grade NYHAⅢ and Ⅳ,and their proportions were 40.6 0.6 and 44.5.Major medication would include nitride(80.0%),diuretics(71.8%),digitalis(68.1%),angiotensin conversion enzyme inhibitors(ACEI)(52. 2 %)andβ-blockers(19. 5 %)etc. Moreover the frequency of above used medication was essentiallyincreasing decade by decade. The major drug treatment of pulmonary heart disease also included diuretics,nitride, digitalis. ACEI was more commonly used in male than in female cases. The frequency of ACEI andARB were more commonly used in the group ≥60 years old than that in the group<60 years old. Theadministration frequency of β一blockers had no significant difference among different age and sexesConclusion The conventional drugs such as nitride,diuretics,digitalis were still dominated the treatment ofCHF.Although the administration frequency of ACEI and (3-Mockers increased quickly,there had been agreat gap between the optimal medical strategy and clinical practice in the management of CHF. Datashowed the treatment strategy was changing.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭